Format

Send to

Choose Destination
Drug Discov Today. 2013 Dec;18(23-24):1133-7. doi: 10.1016/j.drudis.2013.07.013. Epub 2013 Jul 26.

Models for open innovation in the pharmaceutical industry.

Author information

1
Reutlingen University, School of Applied Chemistry, Alteburgstrasse 150, 72762 Reutlingen, Germany. Electronic address: alexander.schuhmacher@reutlingen-university.de.

Abstract

The nature of the pharmaceutical industry is such that the main driver for its growth is innovation. In view of the vast challenges that the industry has been facing for several years and, in particular, how to manage stagnating research and development (R&D) productivity, pharmaceutical companies have opened their R&D organizations to external innovation. Here, we identify and characterize four new types of open innovator, which we call 'knowledge creator', 'knowledge integrator', 'knowledge translator' and 'knowledge leverager', and which describe current open R&D models.

PMID:
23892183
DOI:
10.1016/j.drudis.2013.07.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center